RWD99 Initial Treatment Patterns for Newly Diagnosed, Commercially Insured Patients with Psoriasis

Autor: L Panattoni, J Hernandez, Y Liu, N Sacks, R Higham, B Stephenson, AW Armstrong

Publikováno v: Value in Health. 25:S595

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a91432961ea003ab0b8f17e43e94f962
https://doi.org/10.1016/j.jval.2022.04.1623

Deucravacitinib in Japanese patients with plaque, generalized pustular, or erythrodermic psoriasis: Patient-reported outcomes in the POETYK PSO-4 study.

Autor: Tada Y; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan., Armstrong AW; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.; Division of Dermatology, University of California Los Angeles, Los Angeles, California, USA., Imafuku S; Department of Dermatology, Fukuoka University Hospital Faculty of Medicine, Fukuoka, Japan., Okubo Y; Department of Dermatology, Tokyo Medical University, Tokyo, Japan., Morita A; Department of Geriatrics and Environmental Dermatology, Nagoya City University Graduate School of Medical Science, Nagoya, Japan., Zhong Y; Bristol Myers Squibb, Princeton, New Jersey, USA., Zhuo J; Bristol Myers Squibb, Princeton, New Jersey, USA., Becker B; Bristol Myers Squibb, Princeton, New Jersey, USA., Napoli A; Bristol Myers Squibb, Princeton, New Jersey, USA., Banerjee S; Bristol Myers Squibb, Princeton, New Jersey, USA., Ohtsuki M; Jichi Medical University, Tochigi, Japan.

Publikováno v: The Journal of dermatology [J Dermatol] 2024 Dec 06. Date of Electronic Publication: 2024 Dec 06.

International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting.

Autor: Zhang AJ, Ball G, Zundell MP, Agüero R, Yee D, Shields A, Asare C, Navrazhina K, Liu W, Foolad N, Kwock J, Tejwani P, Hamade H, Jaleel T, Butler D, Silverberg N, Nattkemper L, Siegel DM, Tan J, Kim BS, Larocca C, Shinohara MM, Ehlert A, Latella J, Guttman-Yassky E, Krueger JG, Strand V, Armstrong AW, Merola JF, Perez-Chada L, Gottlieb AB

Publikováno v: Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2024 Dec 01; Vol. 23 (12), pp. 1114-1120.

Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials.

Autor: Korman NJ; Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Bagel J; Psoriasis Treatment Center of New Jersey, East Windsor, NJ, USA., Armstrong AW; University of California Los Angeles, Los Angeles, CA, USA., Gooderham M; SKiN Centre for Dermatology, Peterborough, Queen's University, Kingston, and Probity Medical Research, Waterloo, ON, Canada., Strober B; Yale University School of Medicine, New Haven, and Central Connecticut Dermatology Research, Cromwell, CT, USA., Thaçi D; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany., Morita A; Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan., Imafuku S; Faculty of Medicine, Fukuoka University Hospital, Fukuoka, Japan., Foley P; The University of Melbourne, Parkville, St. Vincent's Hospital Melbourne, Fitzroy, and Probity Medical Research and Skin Health Institute, Carlton, VIC, Australia., Sofen H; University of California Los Angeles, Los Angeles, CA, USA.; Dermatology Research Associates, Los Angeles, CA, USA., Zheng M; The Second Affiliated Hospital and Zhejiang University School of Medicine, Hangzhou, China., Hippeli L; Bristol Myers Squibb, Princeton, NJ, USA., Kisa RM; Bristol Myers Squibb, Princeton, NJ, USA., Banerjee S; Bristol Myers Squibb, Princeton, NJ, USA., Blauvelt A; Oregon Medical Research Center, Portland, OR, USA.

Publikováno v: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2371045. Date of Electronic Publication: 2024 Jun 30.

The impact of insurance status on psoriasis patients' healthcare-seeking behavior: a population-based study in the United States.

Autor: Sadrolashrafi K; Kirk Kerkorian School of Medicine at UNLV, Las Vegas, USA., Hao A; Keck School of Medicine of University of Southern California, Los Angeles, USA., Yamamoto RK; Georgetown University School of Medicine, Washington, DC, USA., Guo L; Duke University School of Medicine, Durham, USA., Kikuchi R; Keck School of Medicine of University of Southern California, Los Angeles, USA., Tolson HC; The University of Arizona College of Medicine - Phoenix, Phoenix, USA., Bilimoria SN; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, 200 Medical Plaza, Los Angeles, CA, 90095, USA., Yee DK; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, 200 Medical Plaza, Los Angeles, CA, 90095, USA., Armstrong AW; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, 200 Medical Plaza, Los Angeles, CA, 90095, USA. armstrongpublication@gmail.com.

Publikováno v: BMC health services research [BMC Health Serv Res] 2024 Nov 29; Vol. 24 (1), pp. 1504. Date of Electronic Publication: 2024 Nov 29.